- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Amyotrophic lateral sclerosis (ALS)
- Meeting Date: March 2026
Edaravone – March 2026
Solution concentrate for I.V. infusion 30 mg in 20 mL
Public Summary Documents
Last updated
11 March 2026
